#EMProfitHunter - Why India Supplies 50% of Global Medicines and Gets 6% of Revenue
China's R&D engine has transformed the global medical landscape.
Indian Pharma 5.0
Here’s an extract…
The shift from manufacturing to invention defines the challenge for Indian pharma.
The historical reliance on generics has left a gap in original drug discovery.
If India is to capture a larger share of global revenue, it must evolve beyond the factory floor of the world.
Read on…
http://www.eqtm.in/g6RZk
Forwarded fromEquitymaster
July 29, 2026 881
